Open Access

[Retracted] Matrix metalloproteinase 14 participates in corneal lymphangiogenesis through the VEGF‑C/VEGFR‑3 signaling pathway

  • Authors:
    • Hai-Tao Du
    • Ping Liu
  • View Affiliations

  • Published online on: January 27, 2025     https://doi.org/10.3892/etm.2025.12809
  • Article Number: 59
  • Copyright : © Du et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

March-2025
Volume 29 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Du H and Liu P: [Retracted] Matrix metalloproteinase 14 participates in corneal lymphangiogenesis through the VEGF‑C/VEGFR‑3 signaling pathway . Exp Ther Med 29: 59, 2025.
APA
Du, H., & Liu, P. (2025). [Retracted] Matrix metalloproteinase 14 participates in corneal lymphangiogenesis through the VEGF‑C/VEGFR‑3 signaling pathway . Experimental and Therapeutic Medicine, 29, 59. https://doi.org/10.3892/etm.2025.12809
MLA
Du, H., Liu, P."[Retracted] Matrix metalloproteinase 14 participates in corneal lymphangiogenesis through the VEGF‑C/VEGFR‑3 signaling pathway ". Experimental and Therapeutic Medicine 29.3 (2025): 59.
Chicago
Du, H., Liu, P."[Retracted] Matrix metalloproteinase 14 participates in corneal lymphangiogenesis through the VEGF‑C/VEGFR‑3 signaling pathway ". Experimental and Therapeutic Medicine 29, no. 3 (2025): 59. https://doi.org/10.3892/etm.2025.12809